Live Breaking News & Updates on American Association Of Geriatric Psychiatry

Stay updated with breaking news from American association of geriatric psychiatry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TTUHSC study: Virus, restrictions increase mental health risks for nursing home caregivers

Ashish Sarangi, M.D., from the Texas Tech University Health Sciences Center recently conducted research into the mental health consequences of COVID-19 geriatric care in a nursing home setting. His research, A Descriptive Study Evaluating the Impact of COVID-19 on Delivery of Care and Mental Health of Geriatric Nursing Home Staff, was published in the April issue of the American Journal of Geriatric Psychiatry. The study also was presented in March during the journal s annual meeting. ....

United States , American Association Of Geriatric Psychiatry , School Of Medicine , Mental Health Of Geriatric Nursing Home Staff , Texas Tech University Health Sciences Center , Ashish Sarangi , Descriptive Study Evaluating , Mental Health , Geriatric Nursing Home Staff , American Journal , American Association , Geriatric Psychiatry , Population Biology , Medicine Health , Health Care Systems Services , Health Professionals , Infectious Emerging Diseases , Mental Health , Stress Anxiety , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் சங்கம் ஆஃப் வயதான மனநல மருத்துவம் , பள்ளி ஆஃப் மருந்து , டெக்சாஸ் தொழில்நுட்பம் பல்கலைக்கழகம் ஆரோக்கியம் அறிவியல் மையம் , மன ஆரோக்கியம் , அமெரிக்கன் இதழ் , அமெரிக்கன் சங்கம் ,

NervGen Pharma Corp.: NervGen Pharma Establishes Alzheimer's Disease Scientific Advisory Board


NervGen Pharma Corp.: NervGen Pharma Establishes Alzheimer s Disease Scientific Advisory Board
Vancouver, British Columbia (Newsfile Corp. - January 26, 2021) -
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ( NervGen or the Company ), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced the formation of its Alzheimer s Disease Scientific Advisory Board ( AD-SAB ) with the appointment of four world-class scientists and clinical researchers in Alzheimer s disease: Jeffrey Cummings, MD, ScD; George Perry, PhD; Henrik Zetterberg, MD, PhD; and Bruce Lamb, PhD. The AD-SAB will work closely with NervGen as the Company plans its upcoming preclinical studies and clinical trials and in the analyses of the results from these studies. ....

United States , United Kingdom , British Columbia , San Diego , San Antonio , University Of Texas , Bruce Lamb , Paul Brennan , Henrik Zetterberg , George Perry , Las Vegas , Kostenloser Wertpapierhandel , Erikk Fernstr , Jeffrey Cummings , Santa Barbara , Huitt Tracey , University College London , American Association Of Geriatric Psychiatry , Nervgen Pharma Corp , Head Of The Department Psychiatry , Sahlgrenska University Hospital , University Of Nevada , Venture Exchange , Regulation Services Provider , American Geriatrics Society , British Columbia Newsfile Corp ,

AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer's disease


Bruno Dubois
Bruno Dubois is currently Professor of Neurology at the Neurological Institute of the Salpétrière University Hospital at Paris, University Pierre et Marie Curie Paris VI. He is Director of the Behavioural Neurology Department and of the Dementia Research Center at the Hospital. He is also Director of the Research Unit Inserm U-610 of the ICM (Institut du Cerveau et de la Moelle Epinière) of the Hospital. He is coordinator of the National Reference Center on Rare Dementias and of the National Reference Center for young-onset Alzheimer patients. He is President of the Scientific Committee of France-Alzheimer and of IFRAD (International Fund Raising for Alzheimer s disease), consultant for the Human Frontier Program and Expert of the French Agency of Drugs. He is a member of the European Alzheimer Disease Consortium (EADC). He has published on anatomical and biochemical studies on the central cholinergic systems in rodents and humans; on cognitive neuropharmacolo ....

Boston University , United States , France General , Los Angeles , City Of , United Kingdom , Noord Holland , Jeffrey Freedman , Bruno Dubois , Philip Scheltens , Las Vegas , Arthur Rouill , Deltaplan Dementie , Queen Square , Moelle Epini , Jeffreyl Cummings , Olivier Hermine , American Association Of Geriatric Psychiatry , Dementia Research Center , Board Of Trustees , Dutch Pearlstring Institute , University Hospital At Paris , Vu University Medical Center , Human Frontier Program , Brain Institute , Alzheimer Imaging Consortium ,